Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Mentis Life Science Corp. C.LIB

Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Comment by rcash1on Nov 06, 2017 1:49pm
93 Views
Post# 26912932

RE:RE:RE:RE:Can't wait to see everyone's faces...

RE:RE:RE:RE:Can't wait to see everyone's faces...
KushMan wrote: Dig deeper and take a look at the qualifications of the people behind the company. 

I'm 100% sure that you will find that they are not "wannabees"

Also, if you take a look at the outfits that already have distribution licenses, you'll find that their market caps are much higher than ours.

Also, I truly believe thers stuff happening behind the scenes that we don't have a clue about..

"Liberty Leaf Holdings is a new Canadian-based public company whose focus is to build and support a diversified portfolio of cannabis sector businesses, including cultivation, value-added cannabidiol/tetrahydrocannabinol products, biotech research and supply chain products within this dynamic and fast-growing sector."

:)


WickedGood wrote:

Just an FYI Lib has value outside of it's distribution. It's market cap is 10mil. Doesn't matter what you think of the company compared to other distributers, but that low market cap screams value play. Thanks for stopping in. 


What I'm saying is, that the value of it's distribution should not increase the value of the company by 50% when nothing else has changed with regards to growing capacity.

It just screams regression. The low market cap is a product of the stock it reflects, a low-worth stock.



You got it Kushman .. Also just to point out people that don't know the drug game , the middleman makes the most $ with the least work ... That margin will be a lot bigger then most think for at least a few years...
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse